Curis
CRIS
#10257
Rank
C$30.6 M
Marketcap
C$0.77
Share price
3.17%
Change (1 day)
-63.26%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): C-$5.20

According to Curis's latest financial reports the company's current EPS (TTM) is C-$5.11. In 2024 the company made an earnings per share (EPS) of C-$9.79 an increase over its 2023 EPS that were of C-$12.57.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.20-46.87%
2024C-$9.79-22.15%
2023C-$12.57-26.17%
2022C-$17.0322.3%
2021C-$13.92-25.37%
2020C-$18.66-30.93%
2019C-$27.01-2.02%
2018C-$27.57
2016C-$62.65-10%
2015C-$69.61138.1%
2014C-$29.2440%
2013C-$20.88-25%
2012C-$27.8466.67%
2011C-$16.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.89-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.82-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.02-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.42 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$15.65 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.96-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA